e-Therapeutics plc (ETX) Insider Steve Medlicott Purchases 200,000 Shares
e-Therapeutics plc (LON:ETX) insider Steve Medlicott acquired 200,000 shares of the business’s stock in a transaction on Friday, December 15th. The shares were purchased at an average price of GBX 9 ($0.12) per share, with a total value of £18,000 ($24,226.11).
Shares of e-Therapeutics plc (LON ETX) opened at GBX 8.75 ($0.12) on Monday. e-Therapeutics plc has a 52 week low of GBX 6 ($0.08) and a 52 week high of GBX 13.12 ($0.18).
WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/e-therapeutics-plc-etx-insider-steve-medlicott-purchases-200000-shares/1771065.html.
e-Therapeutics Company Profile
e-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company’s discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and development. The Company applies its platform to the discovery of new drug candidates.
Receive News & Ratings for e-Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.